Wednesday, October 31, 2018 5:00:15 PM
The Company is presently focused on marketing its Emesyl® homeopathic anti-nausea and its Emesyl® Plus products for retail sale. Presently, Emesyl®The Company is presently focused on marketing its Emesyl® homeopathic anti-nausea and its Emesyl® Plus products for retail sale.
Presently, Emesyl® is available for sale at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com, and Emesyl® Plus is available for sale at https://www.amazon.com/dp/B07H2Z9BHS.
The Company is engaged in efforts to expand all marketing and sales, as well as additional Emesyl®-branded products.
Maybe they are making something of the branded products concept(?).
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM